396 related articles for article (PubMed ID: 26277099)
1. Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
Ho VK; Gijtenbeek JM; Brandsma D; Beerepoot LV; Sonke GS; van der Heiden-van der Loo M
Eur J Cancer; 2015 Nov; 51(17):2508-16. PubMed ID: 26277099
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
[TBL] [Abstract][Full Text] [Related]
3. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
4. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
5. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype.
Matsunaga S; Shuto T; Kawahara N; Suenaga J; Inomori S; Fujino H
J Neurosurg; 2010 Dec; 113 Suppl():65-72. PubMed ID: 21121788
[TBL] [Abstract][Full Text] [Related]
6. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
7. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival.
Ishihara M; Mukai H; Nagai S; Onozawa M; Nihei K; Shimada T; Wada N
Oncology; 2013; 84(3):135-40. PubMed ID: 23235554
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
[TBL] [Abstract][Full Text] [Related]
11. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
12. CNS complications of breast cancer: current and emerging treatment options.
Kaal EC; Vecht CJ
CNS Drugs; 2007; 21(7):559-79. PubMed ID: 17579499
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER.
Brufsky AM; Mayer M; Rugo HS; Kaufman PA; Tan-Chiu E; Tripathy D; Tudor IC; Wang LI; Brammer MG; Shing M; Yood MU; Yardley DA
Clin Cancer Res; 2011 Jul; 17(14):4834-43. PubMed ID: 21768129
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.
Kim HJ; Im SA; Keam B; Kim YJ; Han SW; Kim TM; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Noh DY; Heo DS; Park IA; Bang YJ; Ha SW
J Neurooncol; 2012 Jan; 106(2):303-13. PubMed ID: 21938531
[TBL] [Abstract][Full Text] [Related]
15. CNS metastases in breast cancer.
Lin NU; Bellon JR; Winer EP
J Clin Oncol; 2004 Sep; 22(17):3608-17. PubMed ID: 15337811
[TBL] [Abstract][Full Text] [Related]
16. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
17. Surgical approach to pulmonary metastases from breast cancer.
Kycler W; Laski P
Breast J; 2012; 18(1):52-7. PubMed ID: 22098366
[TBL] [Abstract][Full Text] [Related]
18. Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery.
Rava P; Leonard K; Sioshansi S; Curran B; Wazer DE; Cosgrove GR; Norén G; Hepel JT
J Neurosurg; 2013 Aug; 119(2):457-62. PubMed ID: 23662828
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study.
Ghiringhelli F; Hennequin A; Drouillard A; Lepage C; Faivre J; Bouvier AM
Dig Liver Dis; 2014 Sep; 46(9):854-8. PubMed ID: 24908575
[TBL] [Abstract][Full Text] [Related]
20. Resection of liver metastases in patients with breast cancer: survival and prognostic factors.
van Walsum GA; de Ridder JA; Verhoef C; Bosscha K; van Gulik TM; Hesselink EJ; Ruers TJ; van den Tol MP; Nagtegaal ID; Brouwers M; van Hillegersberg R; Porte RJ; Rijken AM; Strobbe LJ; de Wilt JH;
Eur J Surg Oncol; 2012 Oct; 38(10):910-7. PubMed ID: 22682709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]